Enfusion Files Registration Statement with SEC for Proposed Initial Public Offering

Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based investment management software and services, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its Class A common stock.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Friday, September 17, 2021
Information
Tags: 
Software, Technology, Professional Services, Finance, Goldman Sachs, New, 2nd Floor (Nina song), Security (finance), Sale, USA, U.S. Securities and Exchange Commission, Software, Credit Suisse, Exchange, Varick Street, Form, Company, LLC, BofA Securities, William Blair & Company, Telephone, Prospectus, Financial adviser
Geotags: 
United States, United Kingdom, Hong Kong, Europe, NEW YORK
⚠generated by AI ↴
Summary
Key Points: 
  • Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based investment management software and services, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering of shares of its Class A common stock.
  • The number of shares to be offered and the price range for the proposed offering have not yet been determined.
  • Enfusion intends to list its common stock on the New York Stock Exchange under the ticker symbol ENFN.
  • A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective.


Enfusion, Inc. ("Enfusion"), a leading provider of cloud-based investment management software and services, today announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (“SEC”) relating to a proposed initial public offering of shares of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined. Enfusion intends to list its common stock on the New York Stock Exchange under the ticker symbol “ENFN.”

Morgan Stanley & Co. LLC and Goldman Sachs & Co. LLC will act as lead book-running managers for the proposed offering, with BofA Securities, Credit Suisse Securities (USA) LLC, William Blair & Company, L.L.C., Stifel, Nicolaus & Company, Incorporated and Piper Sandler & Co. acting as other bookrunners.

The offering will be made only by means of a prospectus. Copies of the preliminary prospectus, when available, may be obtained from: Morgan Stanley & Co. LLC, 180 Varick Street, 2nd Floor, New York, New York 10014, Attn: Prospectus Department, by email: [email protected]; Goldman Sachs & Co. LLC, Attn: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at (866) 471-2526 or by email at [email protected].

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Enfusion

Enfusion's investment management software-as-a-service platform removes traditional information boundaries, uniting front-, middle- and back-office teams on one cloud-native system. Through its software, analytics, and middle/back-office managed services, Enfusion creates enterprise-wide cultures of real-time, data-driven intelligence, boosting agility, and powering growth. Enfusion partners with 600+ investment managers from nine global offices spanning four continents.

Copyright: 
Copyright Business Wire 2021